Paper7654476
Aminoglycosides--50 years on.
Begg EJ and 1 other. Br J Clin Pharmacol, 1995. Cited by 224 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Aminoglycosides--50 years on. Papers, record 7654476. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7654476
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminoglycosides | Major topic |
| Animals | |
| Eye Diseases | |
| History, 20th Century | |
| Humans | |
| Kidney Diseases |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3,349,791 | Variability in aminoglycoside pharmacokinetics in critically ill surgical patients. | Crit Care Med | 1988 | https://conductscience.org/library/papers/3349791 | PubMed |
| 2 | 3,288,112 | Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3288112 | PubMed |
| 3 | 3,392,422 | Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia. | J Infect Dis | 1988 | https://conductscience.org/library/papers/3392422 | PubMed |
| 4 | 3,293,977 | Cefotaxime optimal dosage in adult patients. A reappraisal. | Drugs | 1988 | https://conductscience.org/library/papers/3293977 | PubMed |
| 5 | 3,062,000 | General mechanisms of resistance to antibiotics. | J Antimicrob Chemother | 1988 | https://conductscience.org/library/papers/3062000 | PubMed |
| 6 | 2,914,447 | Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients. | Crit Care Med | 1989 | https://conductscience.org/library/papers/2914447 | PubMed |
| 7 | 3,232,800 | Altered aminoglycoside pharmacokinetics in the critically ill. | Anaesth Intensive Care | 1988 | https://conductscience.org/library/papers/3232800 | PubMed |
| 8 | 2,498,520 | Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. | J Med Microbiol | 1989 | https://conductscience.org/library/papers/2498520 | PubMed |
| 9 | 2,745,867 | A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients. | Intensive Care Med | 1989 | https://conductscience.org/library/papers/2745867 | PubMed |
| 10 | 2,764,235 | Incidence of amikacin ototoxicity: a sigmoid function of total drug exposure independent of plasma levels. | Am J Otolaryngol | 1989 | https://conductscience.org/library/papers/2764235 | PubMed |
| 11 | 2,669,624 | Aminoglycoside-induced hearing loss in humans. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2669624 | PubMed |
| 12 | 2,775,614 | Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2775614 | PubMed |
| 13 | 2,775,618 | Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations. | Br J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2775618 | PubMed |
| 14 | 2,681,115 | Determinants of efficacy and toxicity of aminoglycosides. | J Antimicrob Chemother | 1989 | https://conductscience.org/library/papers/2681115 | PubMed |
| 15 | 2,815,234 | Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience. | Ther Drug Monit | 1989 | https://conductscience.org/library/papers/2815234 | PubMed |
| 16 | 2,328,198 | Failure of a nomogram to achieve target aminoglycoside concentrations. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2328198 | PubMed |
| 17 | 2,335,046 | Bayesian forecasting of serum gentamicin concentrations in intensive care patients. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2335046 | PubMed |
| 18 | 2,195,890 | Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone. | Am J Med | 1990 | https://conductscience.org/library/papers/2195890 | PubMed |
| 19 | 2,115,555 | Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. | J Infect Dis | 1990 | https://conductscience.org/library/papers/2115555 | PubMed |
| 20 | 2,202,080 | Aminoglycoside-induced ototoxicity. | Toxicol Lett | 1990 | https://conductscience.org/library/papers/2202080 | PubMed |
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 224 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,473,667 | A rapid point-of-care test for vancomycin monitoring at the clinical bedside. | iScience | 2026 | https://conductscience.org/library/papers/42473667 | PubMed |
| 42,187,863 | Protecting Kidney Health in the First 1000 Days: The Pediatrician's Role in Safeguarding the Weakest. | Diseases | 2026 | https://conductscience.org/library/papers/42187863 | PubMed |
| 41,939,791 | Identification of small molecules that enhance aminoglycoside-mediated suppression of CFTR and NF1 nonsense mutations. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/41939791 | PubMed |
| 41,462,666 | Experimental and Clinical Approaches to Preventing Aminoglycoside-Induced Ototoxicity: A Scoping Review. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41462666 | PubMed |
| 39,180,707 | A universal optical aptasensor for antibiotics determination based on a new high-efficiency Förster resonance energy transfer pair. | Mikrochim Acta | 2024 | https://conductscience.org/library/papers/39180707 | PubMed |
| 38,648,490 | Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38648490 | PubMed |
| 38,465,318 | Comparison of the effects of selected aminoglycoside antibiotics on motor behaviors in mice. | Vet Res Forum | 2024 | https://conductscience.org/library/papers/38465318 | PubMed |
| 38,460,106 | Spider's Silk as a Potential Source of Antibiotics: An Integrative Review. | Probiotics Antimicrob Proteins | 2024 | https://conductscience.org/library/papers/38460106 | PubMed |
| 38,389,933 | The phenomenon of phototoxicity and long-term risks of commonly prescribed and structurally diverse drugs. | J Photochem Photobiol | 2024 | https://conductscience.org/library/papers/38389933 | PubMed |
| 36,777,986 | Targeting Lower Serum Trough Concentrations: A New Gentamicin Dosing Strategy for Suspected Neonatal Early-Onset Sepsis. | J Pediatr Pharmacol Ther | 2023 | https://conductscience.org/library/papers/36777986 | PubMed |
| 36,015,365 | Degradable and Non-Degradable Chondroitin Sulfate Particles with the Controlled Antibiotic Release for Bacterial Infections. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36015365 | PubMed |
| 35,961,964 | Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis. | Bone Res | 2022 | https://conductscience.org/library/papers/35961964 | PubMed |
| 35,664,584 | Nephroprotective Potential of a Standardized Extract of Bambusa arundinacea: In Vitro and In Vivo Studies. | ACS Omega | 2022 | https://conductscience.org/library/papers/35664584 | PubMed |
| 34,188,500 | Resistance Patterns from Urine Cultures in Children Aged 0 to 6 Years: Implications for Empirical Antibiotic Choice. | Infect Drug Resist | 2021 | https://conductscience.org/library/papers/34188500 | PubMed |
| 33,751,142 | Nonsense suppression therapies in human genetic diseases. | Cell Mol Life Sci | 2021 | https://conductscience.org/library/papers/33751142 | PubMed |
| 33,401,760 | Nanotheranostics: A Possible Solution for Drug-Resistant Staphylococcus aureus and their Biofilms? | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/33401760 | PubMed |
| 32,212,706 | How We Think about Targeting RNA with Small Molecules. | J Med Chem | 2020 | https://conductscience.org/library/papers/32212706 | PubMed |
| 32,002,369 | Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis. | Adv Pharm Bull | 2020 | https://conductscience.org/library/papers/32002369 | PubMed |
| 31,775,233 | Development of a Novel Pharmaceutical Formula of Nanoparticle Lipid Carriers of Gentamicin/α-Tocopherol and In Vivo Assessment of the Antioxidant Protective Effect of α-Tocopherol in Gentamicin-Induced Nephrotoxicity. | Antibiotics (Basel) | 2019 | https://conductscience.org/library/papers/31775233 | PubMed |
| 31,739,573 | Antimicrobial Peptides as Anti-Infective Agents in Pre-Post-Antibiotic Era? | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31739573 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7654476
GET https://conductscience.org/api/papers/v1/7654476/references?page=2